Intraoperative Microdialysis for Brain Tumor
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore the use of microdialysis during brain surgery to collect biomarkers, which are measurable indicators of disease presence or severity. The researchers seek to determine if this approach can improve diagnosis and treatment strategies for brain tumors. Participants should have a glioma, a metastatic brain tumor, or an epileptic focus requiring surgical removal. Those undergoing neurosurgery at Mayo Clinic in Rochester, Minnesota, might find this study suitable. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance future brain tumor treatments.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that intraoperative cerebral microdialysis is safe for brain tumor surgery?
Research has shown that using a microdialysis catheter during brain surgery is safe and well-tolerated. In a past study, this tool was successfully used in 10 patients in a coma, collecting important molecules from the brain without causing harm. The catheter is minimally invasive, entering the brain tissue only slightly, which reduces the risk of major side effects.
Additionally, microdialysis has been used to study drug movement through the brain and to gather biomarkers, measurable signs of disease. This process is efficient and has proven effective in live human brain studies. The safety record from these past uses suggests that the procedure is generally well-tolerated, making it a promising option for those considering trials involving brain tumor surgeries.12345Why are researchers excited about this trial?
Researchers are excited about the intraoperative cerebral microdialysis technique for brain tumors because it offers a new way to monitor the chemical environment of the brain in real-time during surgery. Unlike traditional methods that may rely on post-surgical analysis, this approach uses a microdialysis pump and catheter to provide immediate feedback on the biochemical changes occurring in the brain tissue. This real-time monitoring can potentially lead to more precise surgical interventions and a better understanding of tumor behavior, ultimately improving patient outcomes.
What evidence suggests that intraoperative cerebral microdialysis is effective for brain tumors?
Research has shown that intraoperative cerebral microdialysis, a technique participants in this trial will undergo, can be helpful during brain surgery. This method allows doctors to take samples from the brain during the procedure, gathering important information about disease severity or presence. It has been used to monitor brain metabolism, aiding doctors in understanding brain health. The specially designed microdialysis catheter is minimally invasive, causing less disruption to brain tissue. Although still under study, this method shows promise for better diagnosing and treating brain tumors by providing real-time information during surgery.13456
Who Is on the Research Team?
Terence C Burns, MD, PhD
Principal Investigator
Mayo Clinic in Rochester
Are You a Good Fit for This Trial?
Adults (18+) with certain brain tumors or epilepsy needing surgery can join. They should be in fair to good health otherwise, as measured by ECOG performance status. Surgery must be planned at Mayo Clinic in Rochester, MN, and participants need to consent to the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intraoperative Microdialysis
Patients undergo microdialysis over 30 minutes during standard of care biopsy or resection
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Intraoperative cerebral microdialysis using M dialysis 107 pump and 71 High cut-off brain microdialysis catheter
Intraoperative cerebral microdialysis using M dialysis 107 pump and 71 High cut-off brain microdialysis catheter is already approved in United States, European Union for the following indications:
- Central nervous system malignancies
- Traumatic brain injury
- Aneurysmal subarachnoid hemorrhage
- Central nervous system malignancies
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
National Cancer Institute (NCI)
Collaborator